These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 15247883

  • 1. Targeting the chemokine network in renal inflammation.
    Eis V, Vielhauer V, Anders HJ.
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):164-72. PubMed ID: 15247883
    [Abstract] [Full Text] [Related]

  • 2. The role of chemokines and chemokine receptors in progressive renal diseases.
    Segerer S.
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S15-8. PubMed ID: 12612944
    [Abstract] [Full Text] [Related]

  • 3. Chemokine receptor CCR1: a new target for progressive kidney disease.
    Ninichuk V, Anders HJ.
    Am J Nephrol; 2005 Mar; 25(4):365-72. PubMed ID: 16088077
    [Abstract] [Full Text] [Related]

  • 4. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease.
    Anders HJ, Vielhauer V, Schlöndorff D.
    Kidney Int; 2003 Feb; 63(2):401-15. PubMed ID: 12631106
    [Abstract] [Full Text] [Related]

  • 5. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
    Vielhauer V, Anders HJ, Schlöndorff D.
    Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
    [Abstract] [Full Text] [Related]

  • 6. Chemokines and their receptors in allergic disease.
    Pease JE, Williams TJ.
    J Allergy Clin Immunol; 2006 Aug; 118(2):305-18; quiz 319-20. PubMed ID: 16890751
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X, Oppenheim JJ, Howard OM.
    Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S, Hamrah P, Miyamoto K, Miyazaki D, Dekaris I, Dawson T, Lu B, Gerard C, Dana MR.
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
    Yanaba K, Mukaida N, Matsushima K, Murphy PM, Takehara K, Sato S.
    Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of chemokines in the pathogenesis of asthma.
    Lukacs NW.
    Nat Rev Immunol; 2001 Nov; 1(2):108-16. PubMed ID: 11905818
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
    Ninichuk V, Gross O, Reichel C, Khandoga A, Pawar RD, Ciubar R, Segerer S, Belemezova E, Radomska E, Luckow B, Perez de Lema G, Murphy PM, Gao JL, Henger A, Kretzler M, Horuk R, Weber M, Krombach F, Schlöndorff D, Anders HJ.
    J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
    [Abstract] [Full Text] [Related]

  • 20. Chemokines in vascular dysfunction and remodeling.
    Schober A.
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1950-9. PubMed ID: 18818421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.